Clexane 40mg (Enoxaparin): Uses, Dosing, Renal Adjustment, and Reversal
Clexane 40 mg (enoxaparin sodium) is a low molecular weight heparin (LMWH) administered subcutaneously. It potentiates antithrombin III → inhibits Factor Xa and thrombin (IIa) — preventing clot formation/extension.
Approved Indications
- Prophylaxis of DVT: Abdominal, orthopedic (hip/knee replacement), general surgery patients with risk factors
- Prophylaxis of DVT in medical patients: Acute illness, immobility (e.g., heart failure, respiratory failure, stroke, infection)
- Treatment of acute DVT ± PE: 1 mg/kg q12h (40 mg is prophylactic dose only)
- Unstable angina / NSTEMI: 1 mg/kg q12h + aspirin
- STEMI: 30 mg IV bolus + 1 mg/kg SC q12h (age <75)
- Pregnancy-associated VTE prophylaxis/treatment: Preferred anticoagulant (doesn’t cross placenta)
- Hemodialysis: Prevents circuit clotting
Key Points
- 40 mg = prophylactic dose. Therapeutic dose is weight-based (1 mg/kg q12h).
- Renal adjustment: CrCl <30 mL/min → reduce dose / monitor anti-Xa.
- Monitoring: Anti-Xa levels (therapeutic); not routine for prophylaxis.
- Reversal: Andexanet alfa (full); protamine sulfate (partial, ~60%).
- Contraindications: Active major bleeding, HIT, severe thrombocytopenia, hypersensitivity.
Always prescribe per indication, weight, renal function, and guidelines (ACCP, ESC).
Prescription Medications - Related Articles
- Cipro (Ciprofloxacin): Uses, Benefits & Potential Side Effects
- Identify Your Prescription Pills: A Guide to Drug Manufacturers
- Ephedrine: Uses, Benefits & Safety - A Comprehensive Guide
- Musculoskeletal Pain Relief: Medications & Conditions
- Amlodipine Besylate & Diabetes: Understanding the Connection
- Understanding the Safety of FDA-Approved Human Growth Hormone (HGH)
- Polymorphism in Pharmaceuticals: Understanding Crystal Form Variations
